Histone Deacetylase Inhibitors as a Novel Targeted Therapy Against Non-small Cell Lung Cancer: Where Are We Now and What Should We Expect?
暂无分享，去创建一个
G. Tsourouflis | A. Kostakis | N. Andreatos | G. Margonis | A. Karakatsani | D. Dimitroulis | Dimitrios Schizas | K. Kontzoglou | A. Nonni | P. Tomos | C. Kampolis | A. Loukeri | E. Spartalis | C. Damaskos | N. Garmpis | A. Garmpi | E. Antoniou | K. Markatos | M. Spartalis | I. Tomos | Eleni Tsagkari | S. Kokkineli